Viewing Study NCT00248976



Ignite Creation Date: 2024-05-05 @ 12:06 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00248976
Status: COMPLETED
Last Update Posted: 2018-10-29
First Post: 2005-11-03

Brief Title: Improving Health Behavior and Outcomes After Angioplasty
Sponsor: Weill Medical College of Cornell University
Organization: Weill Medical College of Cornell University

Study Overview

Official Title: Improving Health Behavior and Outcomes After Angioplasty
Status: COMPLETED
Status Verified Date: 2018-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The objective of this randomized trials is to evaluate among coronary artery disease patients who have just had either angioplasty or stents whether a novel intervention based on feedback of individualized risk profiles framed as the opportunity to reduce ones biological age is more effective after two years in reducing mortality and major cardiovascular morbidity specifically myocardial infarction stroke class II-IV angina and severe ischemia than the standard risk reduction approach which is framed as ones opportunity to reduce future risk The novel strategy is based on the theory of net-present value and is tested in coronary artery disease patients who have a high risk of adverse outcomes by two years
Detailed Description: 1 To determine whether patients who receive the net-present value intervention have more improvements in their risk factor profile than those in the control group at two years
2 To determine whether the net-present value intervention will enable patients to sustain behavioral change over the long-term
3 To determine whether the net-present value intervention will improve overall functional status and prevent further disability

The long-term objective of this study is to determine whether a net-present value approach for motivation behavior change is effective in reducing risk factors improving treatment outcomes and enhancing quality of life among a high-risk group of patients

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None